Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

SciClone Pharmaceuticals Inc (NASDAQ:SCLN)

8.44
Delayed Data
As of Feb 11
 -0.02 / -0.24%
Today’s Change
6.47
Today|||52-Week Range
11.71
-8.26%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$417.7M

Company Description

SciClone Pharmaceuticals, Inc. engages in the development of therapeutics treatment for cancer and infectious diseases. Its product portforlio includes ZADAXIN, Holxan, Mesna, Endoxan, Farlutal, Methotrexate. Estracyt, Aggrastat, and DC Bead. The company was founded in 1990 and is headquartered in Foster City, CA.

Contact Information

SciClone Pharmaceuticals, Inc.
950 Tower Lane
Foster City California 94404-2125
P:(650) 358-3456
Investor Relations:
(650) 358-1447

Employees

Shareholders

Other institutional41.39%
Mutual fund holders35.61%
Individual stakeholders16.15%

Top Executives

Friedhelm BlobelPresident, Chief Executive Officer & Director
Wai-Shun Wilson CheungCFO, Secretary & SVP-Finance
Charles MengVice President-Compliance & General Counsel
Robert S. KingVice President-Product Development & Manufacturing
Lan XieChief Financial Officer-China Operations